Anne Szarewski

Q: What Schools Are Affiliated With Anne Szarewski

Anne Szarewski is affiliated with the following schools: Queen Mary University of London, London School of Hygiene and Tropical Medicine

Anne Szarewski's AcademicInfluence.com Rankings

Anne Szarewski

Philosophy

#11881

World Rank

#16425

Historical Rank

Logic

#8690

World Rank

#10898

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Anne Szarewski's Degrees

Masters Epidemiology London School of Hygiene and Tropical Medicine

Why Is Anne Szarewski Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Anne Szarewski was a doctor who helped improve how cervical screening samples are tested and was involved in developing the human papillomavirus vaccine. Early life and education Anne Szarewski was born in London in 1959, the only child of older Polish parents. She went to Streatham and Clapham High School for Girls before studying medicine at London's Middlesex Hospital, graduating MBBS in 1982.

(See a Problem?)

Anne Szarewski's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women (2009) (1429)
Overview of the European and North American studies on HPV testing in primary cervical cancer screening (2006) (1089)
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study (2008) (637)
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. (2012) (623)
Management of women who test positive for high-risk types of human papillomavirus: the HART study (2003) (600)
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. (2012) (484)
Human papillomavirus testing in primary cervical screening (1995) (340)
Comparison of Predictors for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears (2008) (239)
Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact (2004) (213)
Comparing the performance of six human papillomavirus tests in a screening population (2013) (187)
Awareness of human papillomavirus among women attending a well woman clinic (2003) (174)
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study (2014) (168)
Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study (2013) (165)
Comparison of Seven Tests for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears: the Predictors 2 Study (2012) (165)
HPV self-sampling as an alternative strategy in non-attenders for cervical screening – a randomised controlled trial (2011) (162)
Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK (2003) (144)
New technologies and procedures for cervical cancer screening. (2012) (137)
The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC‐US or LSIL cervical cytology: A meta‐analysis of the diagnostic accuracy (2013) (131)
Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18 (2012) (124)
Acceptability of unsupervised HPV self-sampling using written instructions (2006) (124)
Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial (2015) (92)
Long‐term follow‐up of cervical abnormalities among women screened by HPV testing and cytology—Results from the Hammersmith study (2008) (90)
Barriers to cervical screening in women who have experienced sexual abuse: an exploratory study (2012) (88)
Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London (2009) (86)
Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation (2013) (86)
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial. (2012) (81)
Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and white British women in Manchester, UK (2004) (81)
Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting (2007) (80)
Effect of smoking cessation on cervical lesion size (1996) (71)
Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study (2010) (63)
The effect of stopping smoking on cervical Langerhans'cells and lymphocytes (2001) (55)
Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis. (2016) (51)
Effect of smoking cessation on cervical lesion size (1996) (51)
Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring. (1993) (51)
Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA (2014) (50)
Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males (2011) (50)
A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes (2014) (48)
Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions (2014) (47)
Oral Contraceptives and Venous Thromboembolism (2010) (47)
Public awareness of human papillomavirus (2006) (42)
Differential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma. (1999) (42)
A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening (2015) (41)
Improving the quality of communication in organised cervical cancer screening programmes. (2008) (41)
Performance of the Abbott RealTime high‐risk HPV test in women with abnormal cervical cytology smears (2010) (37)
Triage of women with minor abnormal cervical cytology: Meta‐analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high‐risk human papillomavirus types (2013) (37)
Cytokeratin expression and acetowhite change in cervical epithelium. (1994) (36)
Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities. (2013) (36)
Depo Provera. Position paper on clinical use, effectiveness and side effects. (1999) (35)
Attitudes towards cytology and human papillomavirus self-sample collection for cervical screening among Hindu women in London, UK: a mixed methods study (2014) (33)
Women's attitudes towards monthly bleeding: Results of a global population-based survey (2012) (32)
Sisters doing it for themselves (2009) (30)
High acceptability and satisfaction with NuvaRing use (2002) (30)
50 years of “The Pill”: celebrating a golden anniversary (2010) (29)
The 'pill scare': the responses of authorities, doctors and patients using oral contraception. (1999) (28)
Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial (2014) (28)
Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel (2006) (26)
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism (2013) (26)
Cervarix®: a bivalent vaccine against HPV types 16 and 18, with cross-protection against other high-risk HPV types (2012) (24)
Cervical screening in adolescents—at least do no harm (2004) (23)
The use of cervicography in a primary screening service. (1991) (23)
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against abnormal cytology and low-grade histopathological lesions in an oncogenic HPV-naïve population (2009) (20)
The use of cervicography in a primary screening service (1991) (19)
A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population—PREDICTORS 4 (2016) (18)
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism (2013) (17)
A comparison of four cytological sampling techniques in a genitourinary medicine clinic. (1990) (16)
Comparison of four cytologic sampling techniques in a large family planning center. (1993) (15)
Oral Contraceptives and Venous Thromboembolism-Consensus Opinion from an International Workshop held in Berlin, Germany in December 2009 (2010) (14)
HPV Vaccination and Cervical Cancer (2012) (14)
Mortality associated with oral contraceptive use (1999) (13)
Cervical screening by visual inspection with acetic acid (2007) (12)
Semiautomated detection of human papillomavirus DNA of high and low oncogenic potential in cervical smears. (1994) (11)
Contraception. Current state of the art. (1991) (11)
DMPA and bone density (1991) (11)
Safety of DMPA (1991) (10)
Social and psychological aspects of cervical screening (2011) (10)
Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer. (2005) (9)
Correction: Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study (2013) (9)
Trends in sexually transmitted infections (other than HIV) in older persons: analysis of data from an enhanced surveillance system (2009) (8)
Prophylactic vaccines for human papillomavirus: a bright future for cervical cancer prevention (2005) (8)
Smoking and cervical neoplasia (2010) (8)
Raising awareness of human papillomavirus and cervical cancer prevention: the need for clinical education (2009) (8)
Cervical smears following laser treatment. Comparison of Cervex brush versus Cytobrush-Ayre spatula sampling. (1991) (7)
HPV vaccines: peering through the fog (2008) (7)
Women’s perceptions about reducing the frequency of monthly bleeding: results from a multinational survey (2013) (7)
The Journal of Family Planning and Reproductive Health Care - Peer Reviewers 2000 (2001) (7)
Keep taking the tablets for HRT (1997) (6)
Prophylactic HPV vaccines. (2007) (6)
Erratum: Testing positive for human papillomavirus in routine cervical screening: Examination of psychosocial impact (BJOG: An International Journal of Obstetrics and Gynaecology (2004) 111 (1437)) (2004) (5)
Spinal bone density in women using depot medroxyprogesterone contraception. (1999) (5)
Use of the Cytobrush for concurrent endocervical cytology and chlamydia sampling. (1990) (5)
Depot medroxyprogesterone acetate and osteoporosis Monitor serum oestradiol concentration in users (1994) (5)
Vaccine efficacy with/without evidence of prior HPV-16/18 infection: analysis of PATRICIA, a phase III trial with AS04-adjuvanted HPV-16/18 vaccine (2009) (5)
BREAST CANCER AND HORMONE EXPOSURE. AUTHORS' REPLY (1996) (3)
Combined oral contraceptive pill and venous thromboembolism (2011) (3)
DEPOT MEDROXYPROGESTERONE ACETATE AND OSTEOPOROSIS (1994) (3)
Risk factors for arterial and venous thrombosis (2008) (3)
Ushering in a new era: human papillomavirus (HPV) testing comes to the NHS Cervical Screening Programme (2011) (3)
O912 Cross‐protective efficacy of Cervarix® against oncogenic types beyond HPV‐16/18: analysis of the according‐to‐protocol (atp) cohort in a double blind, randomized controlled Phase III efficacy trial (2009) (3)
Response rate was only 7.7% (2008) (3)
Study subject to unmeasured confounders and biases (2011) (3)
Choice of contraception (2006) (2)
DiVerential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma (1998) (1)
Oral contraceptives and venous thromboembolism (1997) (1)
High acceptability and satisfaction with NuvaRing use. (2002) (1)
cervical screening context : a qualitative study of Muslim women in London Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the (2009) (1)
Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill is not the second largest RCT. (2013) (1)
Cross-protective efficacy of the AS04-adjuvanted HPV-16/18 vaccine in oncogenic HPV infection-naïve women: results from a double-blind, randomised, phase III trial (PATRICIA) (2009) (1)
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against abnormal cytology and reduction in colposcopy referrals and cervical excisions in an HPV-negative population (2009) (1)
Hormonal contraception: recent advances. (2006) (1)
Testing for HPV cost-effective in women with borderline smears (2000) (1)
Contraception: A Users' Handbook (2000) (1)
Statements on funding and competing interests Funding None identified. Competing interests None identified. (2009) (1)
The combined contraceptive pill. (2003) (1)
Third-generation pill warnings were premature (1997) (1)
Genotyping for HPV 16 and HPV 18 in women with minor cervical 1 lesions : a systematic review and meta-analysis (2017) (1)
Screening and vaccination for cervical cancer (2005) (1)
Discussion (2002) (0)
Germany in December 2009 an International Workshop held in Berlin , Thromboembolism : Consensus Opinion from Oral Contraceptives and Venous (2010) (0)
ORAL CONTRACEPTIVES AND VENOUS THROMBOEMBOLISM. AUTHORS' REPLY (1997) (0)
Revised guidelines for colposcopy aired in Glasgow (1997) (0)
Erratum: Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males (2011) (0)
Jaisamrarn et al PLOS ONE 2013- progression and clearance of HPV infection in PATRICA (2014) (0)
Contraception in the 30-somethings (2013) (0)
Workshop Participants/ Consensus Opinion Contributors (2010) (0)
I335 Cervarix®, the benefits to girls and women: from clinical trials to clinical practice (2009) (0)
Reply (2009) (0)
Reviews : The right method? (1989) (0)
Gardasil: first vaccine for human papillomavirus infection (2007) (0)
Cross-protective efficacy of the AS04-adjuvanted HPV-16/18 vaccine in the total vaccinated cohort (TVC) of PATRICIA, a phase III, double-blind, randomised trial (2009) (0)
Advances in contraception. (1989) (0)
Vaccine choice against HPV: the controversy continues (2008) (0)
Depo Provera and bone density. (2002) (0)
Hormone replacement therapy rings the changes (1996) (0)
Update on contraception. 2: Post-coital and barrier methods. (1995) (0)
Dr Anne Szarewski (2013) (0)
First Asia–Oceania Research Organisation on Genital Infections and Neoplasia (AOGIN) Meeting (2006) (0)
Historical review of the combined oral contraceptive pill and injectable progestogens. (2000) (0)
StudyAbnormal Smears: the Predictors 2 Women Cervical Intraepithelial Neoplasia in Comparison of Seven Tests for High-Grade (2012) (0)
Reply (2006) (0)
Advisory Group on Contraception. Audit Report of the commissioning of contraception & abortion services in England. Sex, Lives and Commissioning (2012) (0)
Oral contraceptives and venous thromboembolism [letter] (1997) (0)
Authors' reply (1991) (0)
Breast cancer and hormone exposure (1996) (0)
Contraception. (1991) (0)
Another flawed database analysis of VTE risk and hormonal contraceptives (2012) (0)
Combined contraceptive update (2010) (0)
CONTRACEPTION AFTER 45 (2009) (0)
Reviews : Assessing barriers (1992) (0)
Colposcopists discuss abnormal smears (1998) (0)
From the Editors (2003) (0)
Confounding in epidemiological studies (1992) (0)
Risk of VTE with COCs containing different progestogens (2017) (0)
Breast cancer and hormone exposure [letter] (1996) (0)
Janet Study with Abnormal Smears : the Predictors 2 WomenCervical Intraepithelial Neoplasia in Comparison of Seven Tests for High-Grade (2012) (0)
Preventing Cervical Cancer (2007) (0)
BARRIERS TO CERVICAL CANCER SCREENING AMONG WOMEN WHO HAVE BEEN ABUSED: AN EXPLORATORY STUDY (2011) (0)
Update on contraception 1: The pill and other hormonal methods. (1995) (0)
women in Manchester, UK Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and white British (2014) (0)
Risk of first cervical HPV infection and precancerous lesions after onset of sexual activity Castellsague (0)
Safety of DMPA [letter] (1991) (0)
EFFECT OF SMOKING CESSATION ON CERVICAL LESION SIZE. AUTHORS' REPLY (1996) (0)
SemiautomatedDetectionof HumanPapillomavirus DNA of Highand Low OncogenicPotentialin CervicalSmears (1994) (0)
containing levonorgestrel desogestrel compared with oral contraceptives contraceptives containing norgestimate or Risk of nonfatal venous thromboembolism with oral (2006) (0)
Oral contraceptives, menopausal treatment, and cancer. (2007) (0)
Prophylactic HPV vaccines – an update (2007) (0)
Di V erential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma (1998) (0)
Cervical samplers (1991) (0)
COCs and VTE risks (2017) (0)
Use of the Cytobrush for Concurrent Cytology and Chlamydia Sampling: A Comparison of Immunofluorescence and Culture for Detection of Chlamydia (1991) (0)
Statement on Duplicate Publication (2009) (0)
Another flawed database study. (2013) (0)

This paper list is powered by the following services:

Other Resources About Anne Szarewski

en.wikipedia.org

What Schools Are Affiliated With Anne Szarewski?

Anne Szarewski is affiliated with the following schools:

Anne Szarewski's Academic­Influence.com Rankings